Bank Julius Baer & Co Portfolio holdings
AUM
$33.7B
1-Year Return
19.52%
This Quarter Return
-2.11%
1 Year Return
+19.52%
3 Year Return
+99.8%
5 Year Return
+152.83%
10 Year Return
–
AUM
$30.6B
AUM Growth
-$1.74B
(-5.4%)
Cap. Flow
-$962M
Cap. Flow
% of AUM
-3.14%
Top 10 Holdings %
Top 10 Hldgs %
33.99%
Holding
683
New
51
Increased
150
Reduced
402
Closed
71
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$163M |
| 2 |
Procter & Gamble
PG
|
+$156M |
| 3 |
Merck
MRK
|
+$148M |
| 4 |
MSCI
MSCI
|
+$130M |
| 5 |
Amphenol
APH
|
+$125M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$392M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$176M |
| 3 |
Broadcom
AVGO
|
+$167M |
| 4 |
Roper Technologies
ROP
|
+$158M |
| 5 |
Intuitive Surgical
ISRG
|
+$133M |
Sector Composition
| 1 | Technology | 27.47% |
| 2 | Financials | 16.57% |
| 3 | Healthcare | 13.09% |
| 4 | Communication Services | 11.16% |
| 5 | Industrials | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
iShares MSCI Canada ETF
EWC
$3.26B
| $199K | ﹤0.01% |
4,320
-7,657
| -64% | -$353K |
|
427
Viking Therapeutics
VKTX
$2.79B
| $193K | ﹤0.01% |
7,078
+2,098
| +42% | +$57.3K |
|
428
CRISPR Therapeutics
CRSP
$5.12B
| $186K | ﹤0.01% |
4,842
-19
| -0.4% | -$731 |
|
429
Vertiv
VRT
$51.5B
| $186K | ﹤0.01% |
2,274
-51
| -2% | -$4.16K |
|
430
Vanguard FTSE Europe ETF
VGK
$27.1B
| $182K | ﹤0.01% |
2,291
+798
| +53% | +$63.3K |
|
431
Zurn Elkay Water Solutions
ZWS
$7.82B
| $181K | ﹤0.01% |
4,866
-118
| -2% | -$4.4K |
|
432
Welltower
WELL
$113B
| $180K | ﹤0.01% |
1,039
+359
| +53% | +$62.1K |
|
433
iShares MSCI South Korea ETF
EWY
$5.52B
| $176K | ﹤0.01% |
2,884
+942
| +49% | +$57.5K |
|
434
DuPont de Nemours
DD
$32.4B
| $175K | ﹤0.01% |
2,071
-46
| -2% | -$3.88K |
|
435
Essential Utilities
WTRG
$10.7B
| $170K | ﹤0.01% |
3,805
-5,891
| -61% | -$263K |
|
436
Global X S&P 500 Catholic Values ETF
CATH
$1.06B
| $170K | ﹤0.01% |
2,223
-583
| -21% | -$44.5K |
|
437
BioMarin Pharmaceuticals
BMRN
$10.4B
| $169K | ﹤0.01% |
+2,121
| New | +$169K |
|
438
D.R. Horton
DHI
$53B
| $167K | ﹤0.01% |
1,163
-185
| -14% | -$26.6K |
|
439
A.O. Smith
AOS
$10.2B
| $163K | ﹤0.01% |
2,212
-2,591
| -54% | -$191K |
|
440
iShares Global ex USD High Yield Corporate Bond ETF
HYXU
$66.6M
| $160K | ﹤0.01% |
2,875
-605
| -17% | -$33.7K |
|
441
Shell
SHEL
$207B
| $157K | ﹤0.01% |
+1,891
| New | +$157K |
|
442
Embraer
ERJ
$10.5B
| $156K | ﹤0.01% |
2,986
-77
| -3% | -$4.02K |
|
443
iShares Core S&P Mid-Cap ETF
IJH
$101B
| $150K | ﹤0.01% |
2,268
-486
| -18% | -$32.1K |
|
444
CVS Health
CVS
$95.1B
| $146K | ﹤0.01% |
1,904
+1,348
| +242% | +$103K |
|
445
Workday
WDAY
$59.6B
| $145K | ﹤0.01% |
+549
| New | +$145K |
|
446
Vale
VALE
$45.5B
| $144K | ﹤0.01% |
12,754
+12,537
| +5,777% | +$141K |
|
447
iShares Core S&P Small-Cap ETF
IJR
$85.7B
| $142K | ﹤0.01% |
1,201
-32,485
| -96% | -$3.84M |
|
448
Klaviyo
KVYO
$9.36B
| $142K | ﹤0.01% |
4,149
-687
| -14% | -$23.5K |
|
449
Dollar General
DG
$23B
| $142K | ﹤0.01% |
1,427
+716
| +101% | +$71.1K |
|
450
Hewlett Packard
HPE
$32.6B
| $142K | ﹤0.01% |
8,130
-2,240
| -22% | -$39.1K |
|